(S)-CR8 ≥97% (by HPLC)

270-509-M005
89148-132EA 296.03 USD
89148-132
(S)-CR8 ≥97% (by HPLC)
(S)-CR8

Inhibitor of CDK and GSK


Potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases (CDKs) 1, 2, 5, 7 and 9. Two to four-fold more potent inhibitor of CDKs than (R)-roscovitine (Prod. No. BML-CC205). Induces apoptotic cell death more potently than (R)-roscovitine. Equally potent inhibitor of CDKs as (R)-CR8 (Prod. No. ALX-270-508). Less potent glycogen synthase kinase (GSK-3alpha/beta) inhibitor than (R)-CR8.


Synthetic.

Formula: C₂₄H₂₉N₇O
CAS Number: 1084893-56-0

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR